Net profit of Sandu Pharmaceuticals declined 9.09% to Rs 0.50 crore in the quarter ended September 2024 as against Rs 0.55 crore during the previous quarter ended September 2023. Sales rose 6.56% to Rs 17.70 crore in the quarter ended September 2024 as against Rs 16.61 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended | ||
Sep. 2024 | Sep. 2023 | % Var. | |
Sales | 17.70 | 16.61 | 7 |
OPM % | 5.14 | 4.94 | - |
PBDT | 0.91 | 0.90 | 1 |
PBT | 0.74 | 0.76 | -3 |
NP | 0.50 | 0.55 | -9 |
Powered by Capital Market - Live News